en

PRODUCT DETAIL

Reblozyl 25 mg prášok na injekčný roztok

Code 5006D
MA number EU/1/20/1452/001
Product Form: plv ino 1x25 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 12 - ANTIANAEMICA
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B03 ANTIANEMIC PREPARATIONS
B03X OTHER ANTIANEMIC PREPARATIONS
B03XA Other antianemic preparations
B03XA06 Luspatercept
Shelf life: 48
Container: glass vial
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 25.06.2020
Validity: 25.06.2025
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 09.03.2023
eu-flag.png sk-flag.png